Pharmafile Logo

Amici Procurement Solutions

Amici provide cutting edge sourcing solutions to companies across the Biotech industry. Our business is to deliver greater savings through improved supplier performance. We can support you whether you are looking for an outsourced procurement resource or simply to save money quickly. We offer consortium deals, consultancy, training and a virtual purchasing resource. Uniquely, we also provide a savings guarantee.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

3 Centura Court, Nasmyth Place, Glasgow, G52 4PR
+44 (0)141 810 2580

 Latest Content from PMHub 

Beyond the patient journey: Designing for behaviour change

In 2016, it’s time to update our model for the customer journey. Customer Experience Consultant Anna Tamasi talks us through the future of journey mapping.

Should We Care About Rare Diseases? By Alastair Kent

Alastair Kent, OBE, the Director of Genetic Alliance UK and chair of Rare Disease UK tells us why it’s so important to care about rare disease and why we should...

Breaking Down the Barriers to Behaviour Change by Patrick Ladbury

Patrick Ladbury, the Director at the NSMC delves further into the barriers to behaviour change, and offers us tricks of the trade in his second instalment.

Affiliate friendly content: e-detailing materials that local markets love

What’s the point of marketing content that doesn’t get used?

Brand teams: They’re not what you think they are

Head of Commercial Matt Bolton of Blue Latitude Health breaks down what we mean when we talk about eliminating the last silos in pharma marketing.

Blue Latitude Health to sponsor and co-present in the Innovation Track at ProcureCon Healthcare 2016

Press Releases | February 19, 2016 | Blue Latitude Health

Blue Latitude Health’s Managing Director, Martin Brass, and Johnson & Johnson’s Director, David McKimm, to co-present on the topic “Optimising Your Marketing Spend in New Ways to Create Value for...

Why are doctors frustrated with the digitalisation of healthcare?

In this article, Customer Experience Consultant Anna Tamasi from Blue Latitude Health highlights the most common usability and user experience implications that the digitalisation of healthcare poses on doctors professional...

Changing faces – overcoming the taboo of marketing to a mature audience

Our new blog highlights the challenges for communicating to consumers who are 50+ and how they must be tackled in order to create marketing opportunities.

It’s time to get with the real world

Lucid CEO discusses the increasing importance placed on real-world data to demonstrate value

Free Thinking: From promise to practice: immuno-oncology in action

White Papers and Resources | February 9, 2016 | Inizio

Our latest Free Thinking white paper series explores what the global outlook is like for new immunotherapy products and asks key opinion leaders and payers how they’re faring both clinically...